Biolinq Inc — Form D/A

Biolinq Inc of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2020-07-07. The offering totals $10.0M, of which $3.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Joshua WindmillerDirectorSan Diego, CA
Joshua WindmillerPromoterSan Diego, CA
Dan BradburyDirectorLa Jolla, CA
CHRIS DIMITROPOULOSDirectorSAN DIEGO, CA
DAVID AFFAS BERRYDirectorSAN DIEGO, CA
DEREK RAPPDirectorSAN DIEGO, CA
ZINA AFFAS BESSEDirectorSAN DIEGO, CA
RICHARD YANGDirectorSAN DIEGO, CA
RICHARD YANGExecutive OfficerSAN DIEGO, CA
THAD JOHNSONDirectorSAN DIEGO, CA
JARED AFFAS TANGNEYExecutive OfficerSAN DIEGO, CA
DAVID AFFAS ARIDAExecutive OfficerSAN DIEGO, CA
JARED TANGNEYDirectorSAN DIEGO, CA
JARED TANGNEYExecutive OfficerSAN DIEGO, CA
JARED TANGNEYPromoterSAN DIEGO, CA
DAVID ARIDAExecutive OfficerSAN DIEGO, CA
Nancy HongDirectorPhiladelphia, PA
Daniel BradburyDirectorPompano Beach, FL
Joshua WindmillerExecutive OfficerSan Diego, CA
Edward KliphuisDirectorSAN DIEGO, CA
Lana GhanemDirectorSAN DIEGO, CA

Other filings by this issuer (11)

FiledFormOfferingSold
2025-03-21D$100.0M$90.0M
2024-09-13D/A$59.1M$59.1M
2024-03-26D/A$58.7M$53.7M
2023-12-26D$50.0M$35.1M
2022-06-01D/A$105.6M$77.9M
2021-09-17D$109.5M$62.2M
2021-03-23D$6.0M$5.2M
2020-04-07D$8.0M$3.6M
2019-03-20D$3.0M$3.0M
2017-11-27D$13.1M$8.1M
2016-09-28D$750K$450K

More